The average of price targets set by Wall Street analysts indicates a potential upside of 33.5% in SelectQuote (SLQT). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
SelectQuote, Inc. (NYSE:SLQT ) Q2 2025 Results Conference Call February 10, 2025 5:00 PM ET Company Participants Matt Gunter - Investor Relations Tim Danker - Chief Executive Officer Ryan Clement - Chief Financial Officer Bob Grant - President Conference Call Participants Benjamin Hendrix - RBC Capital Markets George Sutton - Craig Hallum Pat McCann - NOBLE Capital Markets Operator Good afternoon, ladies and gentlemen, and thank you for standing by. My name is Kelvin, and I will be your conference operator today.
SelectQuote (SLQT) came out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.11 per share a year ago.
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) (the “Company”), a leading distributor of Medicare insurance policies and owner of a rapidly-growing healthcare services platform, today announced that the Company signed a $350 million strategic investment from funds managed by Bain Capital, Morgan Stanley Private Credit, and Newlight Partners. The transaction positions the Company to continue growing its healthcare services business, deepening its relationship with carrier p.
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT), a leading distributor of Medicare insurance policies and owner of a rapidly growing Healthcare Services platform, today announced it will release its first quarter 2025 financial results before market open on Monday, November 4, 2024. Chief Executive Officer, Tim Danker, and Chief Financial Officer, Ryan Clement, will host a conference call on the day of the release (November 4, 2024) at 8:30 am ET to discuss the results. To.
It might be surprising for some to hear that 2024 has been a great year for stocks in the insurance industry. In fact, every single large-cap insurance stock in the United States and Canada trading region has a positive return this year.
SelectQuote offers a range of insurance products, including Medicare Advantage, life, home, and auto insurance, making it a versatile broker. The company is also expanding strongly into pharmacy fulfillment through the buildout of SelectRx. The market had a strong negative reaction to the results for the fiscal year ended 6/30/24 and guidance provided.
SelectQuote, Inc. (NYSE:SLQT ) Q4 2024 Earnings Conference Call September 13, 2024 8:30 AM ET Company Participants Matt Gunter - IR Tim Danker - CEO Ryan Clement - CFO Bob Grant - President Bill Grant - COO Conference Call Participants Ben Hendrix - RBC Capital Markets Patrick McCann - Noble Capital Markets Operator Hello, and welcome to SelectQuote's Fourth Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise.
OVERLAND PARK, Kan.--(BUSINESS WIRE)--SelectQuote, Inc. (NYSE: SLQT) reported consolidated revenue for the fourth quarter of fiscal year 2024 of $307.2 million compared to consolidated revenue for the fourth quarter of fiscal year 2023 of $221.8 million. Consolidated net loss for the fourth quarter of fiscal year 2024 was $31.0 million compared to consolidated net loss for the fourth quarter of fiscal year 2023 of $47.8 million. Finally, consolidated Adjusted EBITDA* for the fourth quarter of f.
Net income missed an analyst's estimate, while revenue beat. The company's guidance for fiscal 2025 appears to have come up short of expectations by a healthy margin.